Will Factor XI Be the Goldilocks Anticoagulant Target?

Sep 22 2023 This Week in CardiologyПодробнее

Factor XI inhibitors: what should clinicians know?Подробнее

ICU 2.0: Revolutionizing Anticoagulation!Подробнее

Emerging Solutions for Safer Anticoagulation: Why Factor XI?Подробнее

FXIa inhibition for secondary stroke prevention: current evidenceПодробнее

Journal Club - Less Bleeding With Factor XI Inhibitor- PACIFIC AF trialПодробнее

Hematologist's Introduction Factor XI/XIaПодробнее

Factor XI/XIa Inhibition as a Target for Anticoagulation: The What, Why, and HowПодробнее

Hemophilia C (Factor XI deficiency)Подробнее

Looking into the future of anticoagulationПодробнее

Hemophilia C / Rosenthal syndrome / Factor XI deficiencyПодробнее

Factor XI Paula Bolton MaggsПодробнее

Haemostasis 6: Anticoagulant FactorsПодробнее

Predicting High Risk of Bleeding - Phil WellsПодробнее

PACIFIC-Stroke: the first RCT comparing factor XIa inhibition versus placeboПодробнее

Coagulation: Factors and AnticoagulantsПодробнее

What are the Blood Clotting Risk Genes?Подробнее

S3E11 - What is Factor parallelism for?Подробнее

Dr. Dan Bloomfield on the Benefits of AbelacimabПодробнее

Rare Factor DeficienciesПодробнее